Your browser doesn't support javascript.
loading
Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study.
Gavín, Olga; Roldán, Vanessa; Llamas-Sillero, Pilar; Santamaría, Amparo; Arumí, Daniel; Cabo, Susana Fernández de.
Afiliación
  • Gavín O; H. Clínico Universitario Lozano Blesa, Spain. Electronic address: ogavin@hotmail.es.
  • Roldán V; H. General Universitario Morales Meseguer, Spain.
  • Llamas-Sillero P; H. Universitario Fundación Jiménez Díaz, Spain.
  • Santamaría A; H. Universitarios Vinalopó y Torrevieja, Spain.
  • Arumí D; Medical Department, Pfizer, Spain.
  • Cabo SF; Medical Department, Pfizer, Spain.
Med Clin (Barc) ; 159(8): 366-371, 2022 10 28.
Article en En, Es | MEDLINE | ID: mdl-35120766
INTRODUCTION AND OBJECTIVE: In Spain, vitamin K antagonists (VKA) remain the standard treatment for the prevention of thromboembolic and hemorrhagic complications in patients with atrial fibrillation (AF), despite the high risks of suffering adverse effects. The objective of this study was to characterize the profile of VKA-treated patients suffering from stroke/systemic embolism (SE) or major hemorrhagic episodes, their evolution and the actions taken after those episodes. MATERIALS AND METHODS: EVENTHO was an observational multicenter study conducted in 22 Anticoagulation Spanish Units. The study included patients ≥18 years with AF who suffered major hemorrhagic episodes (67.8%) or stroke/SE (32.1%) during 2016 whileon VKA treatment [acenocoumarol (98.2%) or warfarin (1.8%)]. Time in therapeutic range (TTR) was calculated according to the Rosendaal method based on the international normalized ratio (INR) values of the previous 6 months. RESULTS: The study included 585 patients (median age [range] 82.3 [43.6-96.2] years; 51.1% men; mean [95% confidence interval, CI] CHA2DS2-VASc: 4.3 [4.2-4.4] and HAS-BLED: 2.2 [2.1-2.3]). Poor anticoagulation and VKA maintenance were higher in patients with major hemorrhagic episode (p<0.0001). The most common situations after hospital discharge were: functional dependence, neurological sequelae and death. CONCLUSIONS: In the sample studied, half of the AF patients who suffered stroke/SE or major hemorrhagic episode had inadequate TTR and, despite this, after hospital discharge, they restarted treatment with VKA. These results highlight the need to evaluate safer and effective therapeutic alternatives in AF patients with poor TTR control after suffering a stroke/SE or major hemorrhagic episode.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Accidente Cerebrovascular Tipo de estudio: Clinical_trials Límite: Aged80 / Female / Humans / Male Idioma: En / Es Revista: Med Clin (Barc) Año: 2022 Tipo del documento: Article Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Accidente Cerebrovascular Tipo de estudio: Clinical_trials Límite: Aged80 / Female / Humans / Male Idioma: En / Es Revista: Med Clin (Barc) Año: 2022 Tipo del documento: Article Pais de publicación: España